Barclays
ARDT

Barclays’s Ardent Health ARDT Stock Holding History

Barclays’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
20,319
+9,490
+88% +$90K ﹤0.01% 3710
2026
Q1 		$92.7K Sell
10,829
-25,308
-70% -$227K ﹤0.01% 4055
2025
Q4 		$319K Buy
36,137
+812
+2% +$9.39K ﹤0.01% 4100
2025
Q3 		$468K Sell
35,325
-3,195
-8% -$40K ﹤0.01% 3856
2025
Q2 		$526K Sell
38,520
-902
-2% -$12.1K ﹤0.01% 3731
2025
Q1 		$542K Buy
39,422
+13,245
+51% +$193K ﹤0.01% 3479
2024
Q4 		$447K Buy
26,177
+5,185
+25% +$89.9K ﹤0.01% 3890
2024
Q3 		$386K Buy
+20,992
New +$371K ﹤0.01% 3932

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's ARDT Position: Q2 2026 in Review

Barclays increased its Ardent Health (ARDT) stake by 88% in Q2 2026, buying an estimated $90K and bringing the position to 20,319 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #3710.

Barclays first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $542K in Q1 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Barclays held 20,319 shares of Ardent Health worth $200K as of Q2 2026.
  • Barclays bought 9,490 Ardent Health shares in Q2 2026, an estimated $90K.
  • Ardent Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3710 holding.
  • Barclays first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • Barclays's Ardent Health position peaked at $542K in Q1 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.